BackProgenity Overview

Progenity Total Assets

Track Progenity's total assets ($15M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$14.51M
↓ 58.20% YoYΔ $-20.20M vs prior year quarter

Peer trimmed avg / median

Loading

Progenity Total Assets History

Loading

Progenity vs. peers: Total Assets Comparison

Loading

Progenity Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Progenity (PROG) FAQ

Progenity (PROG) currently reports a total assets of $15M as of September 2024. That compares with $35M in the prior-year period — down 58.2% year over year. Use the charts on this page to explore Progenity's total assets history and peer comparisons.

Progenity's total assets decreased from $35M to $15M — a 58.2% year-over-year decrease (period ending September 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Progenity reported $15M in total assets as of September 2024. That compares with $35M in the prior-year period — down 58.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total assets of $15M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Progenity, and consider following PROG for alerts when major investors trade the stock.

Progenity is classified in the Healthcare sector. On total assets, it currently shows $15M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PROG with unrelated industries.